Loading company…
Riskpilot
← Back to search
Sign in
Get full access
LYSE BIO AS
AS
Active
Org 932803658
Breiflåtveien 18, 4017 Stavanger
Production of electricity from renewable sources · NACE 3512
Est. 2024
5 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
1.6%
Financial strength
Net profit 2024
NOK -1,3M
5 employees
EBITDA — year on year
NOK millions
0M
-1M
-1M
-2M
-3M
-2M
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -1,7M
—
Net profit
NOK -1,3M
—
Total assets
NOK 1,9M
—
Equity
NOK 30K
—
Employees
5
—
Company information
Legal name
LYSE BIO AS
Org number
932803658
Legal form
Aksjeselskap
NACE code
3512 · Production of electricity from renewable sources
Founded
10. januar 2024
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikle, produsere, bygge og investere i anlegg for produksjon av bioenergi, samt beslektet type virksomhet.
Contact
Address
Breiflåtveien 18, 4017 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Production of electricity from renewable sources
Companies in Stavanger
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
NOK millions
0M
-1M
-1M
-2M
-2M
-2M
2024
Income statement
NOK thousands
Item
2024
Revenue
0
Staff expenses
−1 510
EBITDA
−1 714
Depreciation & amort.
−0
EBIT
−1 714
Net financials
−5
Profit before tax
−1 718
Tax
−378
Net profit
−1 340
Balance sheet
NOK thousands
Item
2024
Total assets
1 858
Equity
30
Long-term debt
0
Short-term debt
1 828
Total debt
1 828
Financial ratios
5-year trend
EBITDA margin
-171350900.0%
This company
15.8%
Market median
-1084499467% vs market
2024
2024
Equity ratio
1.6%
This company
38.2%
Market median
-96% vs market
2024
2024
Return on equity
-4468.1%
This company
18.4%
Market median
-24383% vs market
2024
2024
Net profit margin
-134042500.0%
This company
8.1%
Market median
-1654845779% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
60.95×
This company
0.62×
Market median
-9731% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-11-27 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
ET
Esben Tonning Otterlei
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
RF
Rosalie Francine Petronella Poen
Board of Directors
2025
TH
Tord Helland
Chairman
2024
IV
Ingrid Vestvik
Board of Directors
2024
EB
Eirik Brekne Aanestad
Board of Directors
2024
UR
Unni Røsok Thornes
Board of Directors
2025
SG
Svein Grude
Chairman
2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Lyse As
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Sandnes Kommune
Lyse As
LYSE BIO AS
(this company)
Board network connections
Board members of LYSE BIO AS also hold positions in
0
other companies.
Person
Role here
Other companies
Esben Tonning Otterlei
Chief Executive Officer
0 companies
Rosalie Francine Petronella Poen
Board of Directors
0 companies
Tord Helland
Chairman
0 companies
Ingrid Vestvik
Board of Directors
0 companies
Eirik Brekne Aanestad
Board of Directors
0 companies
Unni Røsok Thornes
Board of Directors
0 companies
Svein Grude
Chairman
0 companies